Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The A.B. Bekturov Institute of Chemical Sciences is a prominent research and development institution based in Almaty, Kazakhstan, specializing in chemical sciences and pharmacology. Established in 1945, the institute operates as a Joint Stock Company and is currently integrated into the Satbayev University research ecosystem. Its primary activities include the synthesis of bioactive compounds, the development of new polymer materials, and the creation of specialized fertilizers. The institute has a strong track record in medicinal chemistry, having developed and commercialized several pharmaceutical products such as the local anesthetic Richlokain and the anti-tuberculosis drug Glikatsid. It maintains extensive collaborations with international research centers and focuses on translating fundamental chemical research into industrial and clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Chemical Sciences (Kazakhstan).